(Q28192000)

acute myocardial infarction

inferred from title

1 reference

W S Aronow

1

0 references

language of work or name

English

0 references

publication date

2001

0 references

published in

Drugs & Aging

0 references

volume

18

0 references

issue

11

0 references

page(s)

807-18

0 references

cites work

Evaluating effects of treatment in subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers.

1 reference

12 December 2020

Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries

1 reference

12 December 2020

1 reference

12 December 2020

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

12 December 2020

Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group

1 reference

12 December 2020

Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use

1 reference

12 December 2020

Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group

1 reference

12 December 2020

Thrombolytic therapy in older patients

1 reference

12 December 2020

Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials

1 reference

12 December 2020

Effect of propranolol on circadian variation of myocardial ischemia in elderly patients with heart disease and complex ventricular arrhythmias

1 reference

12 December 2020

Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients > or = 62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction > or = 4

1 reference

12 December 2020

Postinfarction use of beta-blockers in elderly patients

1 reference

12 December 2020

Aspirin as an antiplatelet drug

1 reference

12 December 2020

Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group

1 reference

12 December 2020

Utility of Beta‐Blockade Treatment for Older Postinfarction Patients

1 reference

12 December 2020

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis

1 reference

12 December 2020

Use and effectiveness of intravenous heparin therapy for treatment of acute myocardial infarction in the elderly

1 reference

12 December 2020

Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. AIMS Trial Study Group

1 reference

12 December 2020

Beta-blocker therapy in the cardiac arrhythmia suppression trial

1 reference

12 December 2020

Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias

1 reference

12 December 2020

Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy

1 reference

12 December 2020

Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators

1 reference

12 December 2020

Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Gruppo Italiano per lo Studio della Streptochi-nasi nell'Infarto Miocardico (GISSI)

1 reference

12 December 2020

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

12 December 2020

Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Mio

1 reference

12 December 2020

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

12 December 2020

The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group

1 reference

12 December 2020

Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison

1 reference

12 December 2020

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)

1 reference

12 December 2020

1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Comm

1 reference

12 December 2020

Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis

1 reference

12 December 2020

Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction.

1 reference

12 December 2020

Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collabor

1 reference

12 December 2020

Effect of concomitant or very early statin administration on in-hospital mortality and reinfarction in patients with acute myocardial infarction

1 reference

12 December 2020

The effect of diltiazem on mortality and reinfarction after myocardial infarction

1 reference

12 December 2020

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

12 December 2020

Trends in acute myocardial infarction and coronary heart disease death in the United States

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect

1 reference

12 December 2020

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

12 December 2020

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

1 reference

12 December 2020

Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients

1 reference

12 December 2020

Drug Treatment After Acute Myocardial Infarction: Is Treatment the Same for the Elderly as in the Young Patient?

1 reference

12 December 2020

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

1 reference

12 December 2020

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

12 December 2020

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

1 reference

12 December 2020

Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction

1 reference

12 December 2020

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

12 December 2020

Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.

1 reference

12 December 2020

Effect of propranolol on circadian variation of ventricular arrhythmias in elderly patients with heart disease and complex ventricular arrhythmias

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

12 December 2020

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

12 December 2020

Aspirin in the Treatment of Acute Myocardial Infarction in Elderly Medicare Beneficiaries : Patterns of Use and Outcomes

1 reference

12 December 2020

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

1 reference

12 December 2020

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

12 December 2020

Rationale and design of the magnesium in coronaries (MAGIC) study: A clinical trial to reevaluate the efficacy of early administration of magnesium in acute myocardial infarction.

1 reference

12 December 2020

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

1 reference

12 December 2020

Trial of early nifedipine in acute myocardial infarction: the Trent study

1 reference

12 December 2020

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

12 December 2020

Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics

1 reference

12 December 2020

Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction

1 reference

12 December 2020

Heparin for acute myocardial infarction: the controversy continues

1 reference

12 December 2020

Association of calcium channel blocker use with increased rate of acute myocardial infarction in patients with left ventricular dysfunction

1 reference

12 December 2020

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

12 December 2020